Agios Pharmaceuticals, Inc. (AGIO) P/S ratio

P/S ratio today
32.1×

Agios Pharmaceuticals, Inc. (AGIO) trades at 32.1× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 29.2×. That is 44.0% lower than the 52.1× of fiscal 2024. Figures as of 18 Nov 2026, 06:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
32.1×
P/S ratio, fiscal 2025
29.2×
Change on fiscal 2024
−44.0%
Highest on record
108.0×fiscal 2022
Lowest on record
24.3×fiscal 2019
Fiscal years on record
52019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Agios Pharmaceuticals, Inc. P/S ratio, in more detail

Today's figure is 9.8% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2019–2025), the highest was 108.0× in fiscal 2022 and the lowest 24.3× in fiscal 2019. Today's P/S ratio is higher than at 40% of the 5 fiscal year-ends on record; their median is 46.2×.

History · 5 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Agios Pharmaceuticals, Inc. P/S ratio, year by year

Agios Pharmaceuticals, Inc. (AGIO) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today32.1×—$29.89—
202529.2× 44.0% down$27.22$0.93
202452.1× 12.8% up$32.86$0.63
202346.2× 57.2% down$22.27$0.48
2022108.0×—$28.08$0.26
2021——$32.87—
2020——$43.33—
201924.3×—$47.75$1.97
2018——$46.11—
2017——$57.17—
2016——$41.73—
2015——$64.92—
2014——$112.04—
2013——$23.95—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on AGIO

Agios Pharmaceuticals, Inc., figure by figure

Agios Pharmaceuticals, Inc. (AGIO) overview: price, valuation and scorecard

Agios Pharmaceuticals, Inc. P/S ratio: questions and answers

What is Agios Pharmaceuticals, Inc.'s P/S ratio?

Agios Pharmaceuticals, Inc. (AGIO) trades at 32.1× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 29.2×. That is 44.0% lower than the 52.1× of fiscal 2024.

Is Agios Pharmaceuticals, Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 40% of the 5 fiscal year-ends on record; their median is 46.2×.

What are the highest and lowest P/S ratio figures on record for Agios Pharmaceuticals, Inc.?

Across the 5 fiscal year-ends on record (2019–2025), the highest was 108.0× in fiscal 2022 and the lowest 24.3× in fiscal 2019.

How is Agios Pharmaceuticals, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Agios Pharmaceuticals, Inc. (AGIO) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/AGIO/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.